The best bet at arriving at the truth about uptake and impact is to focus on hard statistics — numbers, ratios, and ...

MODY 5 is a rare genetic diabetes subtype caused by HNF1B mutations or deletions, often presenting with early-onset diabetes and kidney, liver, or pancreatic abnormalities. Accurate genetic diagnosis ...

Ankyra Therapeutics is a biotech developing anchored immunotherapies aimed at enhancing the therapeutic window of ...

As rising cases revive fears, the dangers of a lingering post-Covid syndrome that puts patients at risk long after recovery cannot be emphasised more ...

RADNOR, PA — Mineralys Therapeutics, Inc. (Nasdaq: MLYS) has announced detailed results from its pivotal Phase 3 Launch-HTN ...

A graduate of the University of Virginia and now based in the UK, Jimmy has been following the development of blockchain for several years, optimistic about its potential to democratize the ...

Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, today announced the publication of its study investigating Caldolor® (intravenous ibuprofen) in older patients. The ...

The second and final closed beta test for free-to-play fantasy adventure RPG Duet Night Abyss will run for PC, iOS, and Android from June 12 to July 2, publisher Hero Games and developer PAN ...

Strawberries, cherries and an angel’s kiss in spring, my summer wine is really made from all these things. Okay, so the ...

FILSPARI holds strong market potential as the first FDA-approved non-immunosuppressive therapy for IgA nephropathy, a rare kidney disease with significant unmet needs. As more patients and providers ...

Outstanding service, teaching, scientific achievements, and other efforts were celebrated at the Jacobs School of Medicine and Biomedical Sciences 2025 Faculty and Staff Recognition Awards event.